Evidence map›Paper›PMID 42838964›Full record

ArticleNature communications2026

Suppressing glutamate dehydrogenase guides hematopoietic stem cell divisions into self-renewal.

Michihiro Hashimoto, Michie Uchikawa, Yuichiro Arima, Akiyasu Iwase, Ayano Yahagi, Mizuki Ishimaru, Tomomasa Yokomizo, Ayako Nakamura-Ishizu, Yosuke Tanaka, Kenichi Miharada and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michihiro HashimotoLaboratory of Hematopoietic Stem Cell Engineering, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Michie UchikawaLaboratory of Hematopoietic Stem Cell Engineering, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yuichiro ArimaDepartment of Anatomy, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-9840-3347
Akiyasu IwaseIsotope Science Center, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9095-5879
Ayano YahagiDepartment of Microscopic Anatomy and Developmental Biology, Tokyo Women's Medical University, Tokyo, Japan.
Mizuki IshimaruLaboratory of Hematopoietic Stem Cell Engineering, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tomomasa YokomizoDepartment of Microscopic Anatomy and Developmental Biology, Tokyo Women's Medical University, Tokyo, Japan.ORCID 0000-0001-6157-2852
Ayako Nakamura-IshizuDepartment of Microscopic Anatomy and Developmental Biology, Tokyo Women's Medical University, Tokyo, Japan.ORCID 0000-0002-5187-7553
Yosuke TanakaLaboratory of Stem Cell Regulation, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0002-8538-0916
Kenichi MiharadaLaboratory of Proteostasis in Stem Cell, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0001-8073-4001
Hiroki KuriharaIsotope Science Center, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6476-5593
Goro SashidaLaboratory of Transcriptional Regulation in Leukemogenesis, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan.ORCID 0000-0003-2318-5987
Toshio SudaLaboratory of Stem Cell Regulation, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan. sudato@keio.jp.ORCID 0000-0001-7540-1771
Terumasa UmemotoLaboratory of Hematopoietic Stem Cell Engineering, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan. umemoto@kumamoto-u.ac.jp.ORCID 0000-0003-0423-9003

Funding

Chinese Academy of Medical Sciences (CAMS) CIFMS; 2024-12M-3-017Japan Agency for Medical Research and Development (AMED) jp24bm1123050s0201Japan Agency for Medical Research and Development (AMED) jp24ym0126804j0003MEXT | Japan Society for the Promotion of Science (JSPS) 23K17343MEXT | Japan Society for the Promotion of Science (JSPS) 24K22135National Natural Science Foundation of China (National Science Foundation of China) W2441024
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) self-renew to expand their pool but often differentiate upon division. Thus, it remains unclear how HSCs maintain their stemness during or after division. Here, we show that the suppression of glutamate dehydrogenase (Glud1), a key enzyme responsible for glutamate (Glu) catabolism, supports the maintenance of HSCs during division. We find that self-renewing mouse HSCs during hematopoietic regeneration exhibited lower intracellular Glu levels compared to HSCs differentiating during ex vivo culture. We therefore focus on the negative regulation of Glu catabolic reactions as a candidate factor to maintain HSCs during division, and find that treatment with the Glud1 inhibitor, R162, maintains a subset of HSCs that would otherwise differentiate during division under normal culture conditions. This treatment successfully results in an approximately 500-fold expansion of functional mouse HSCs that maintain expression pattern of conventional stem cell markers over a 30-day culture period. Importantly, this positive effect of Glud1 inhibition is independent of suppressing cell divisions and dependent on robust JAK2-STAT signaling. Overall, our findings propose that Glud1 inhibition, coupled with robust JAK2-STAT signaling, characterizes a functional HSC state during division, enabling ex vivo expansion of mouse HSCs under conventional culture conditions.

Indexed as

Cell DivisionCell Self RenewalGlutamate DehydrogenaseHematopoietic Stem CellsAnimalsCell DifferentiationCells, CulturedGlutamic AcidJanus Kinase 2MiceMice, Inbred C57BLSignal TransductionGlutamate DehydrogenaseGlutamic AcidJak2 protein, mouseJanus Kinase 2

Identifiers

PMID42838964
PMCPMC13642937

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.